Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Development of paradoxical inflammatory disorders during treatment of psoriasis with TNF inhibitors: a review of published cases

Publikation: Bidrag til tidsskriftReviewForskningpeer review

DOI

  1. Necrotic ulcer on the chin of a previously healthy 38-year-old woman

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. The effect of anti-IL-17 treatment on the reaction to a nickel patch test in patients with allergic contact dermatitis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Comorbidities in vitiligo: comprehensive review

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  4. Patient-reported outcomes (PROs) in chronic urticaria

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  5. Autoinflammatory syndromes associated with hidradenitis suppurativa and/or acne

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  1. The prevalence of atopic dermatitis in adults: systematic review on population studies

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Socioeconomic Costs and Health Inequalities from Psoriasis: A Cohort Study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Omalizumab for atopic dermatitis: evidence for and against its use

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Treatment of atopic dermatitis with dupilumab: experience from a tertiary referral centre

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

BACKGROUND: TNF inhibitors have proven to be effective and relatively safe in the management of psoriasis. While infections and certain malignancies are established as acknowledged side effects, paradoxical inflammatory, non-neoplastic, noninfectious adverse events are being recognized less frequently. We aimed to identify published, peer-reviewed cases of paradoxical inflammatory, non-neoplastic, noninfectious adverse events in psoriasis patients during TNF inhibitor therapy.

METHODS: A literature search in MEDLINE was performed for articles published from inception through the 8th of June 2016 that reported suspected incidents fulfilling a predefined search strategy. In addition, articles identified by reference lists were added.

RESULTS: A total of 295 cases from various organ systems among 13 269 patients were identified: 91 cases were related to infliximab, 101 cases were related to etanercept, and 102 cases were related to adalimumab. One case report was related to both etanercept and adalimumab.

CONCLUSION: Induction of paradoxical non-neoplastic noninflammatory adverse events in psoriasis patients treated with a TNF inhibitor is worth recognizing. The amount of cases identified by this study suggests that continuous surveillance and research into these adverse effects is relevant. Nondermatologic paradoxical inflammatory reactions may be underreported.

OriginalsprogEngelsk
TidsskriftInternational Journal of Dermatology
Vol/bind56
Udgave nummer11
Sider (fra-til)1087-1102
Antal sider16
ISSN0011-9059
DOI
StatusUdgivet - nov. 2017

ID: 52407601